Vimarsana
Biggest News Aggregation in the World

Anu Osinusi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Anu Osinusi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Anu Osinusi Today - Breaking & Trending Today

Omicron Problem For Doctors: How To Know What To Prescribe : World News - Vimarsana News

Omicron Problem For Doctors: How To Know What To Prescribe : World News

Omicron Problem For Doctors: How To Know What To Prescribe : Rashtra News Omicron Variant: Omicron has the potential to soon comprise a bigger share of the Covid cases.The omicron variant presents a new problem for doctors: Some drugs may work better than others, but knowing what to prescribe will hinge on quickly figuring out

Navigating COVID: Why it still matters - Vimarsana News

Navigating COVID: Why it still matters

Backed by a strong heritage in virology and research and development, Dr. Osinusi is confident Gilead is built to continue to address unmet needs in the COVID-19 pandemic, as well as future pandemics because as Dr. Osinusi puts it, the next pandemic is not a matter of if, but rather of when.

Gilead to Present Late Breaking Data and Real World Evidence Highlighting Key Hepatitis Indications at The Liver Meeting® 2023 - Vimarsana News

Gilead to Present Late Breaking Data and Real World Evidence Highlighting Key Hepatitis Indications at The Liver Meeting® 2023

– Three Oral Presentations and 30 Posters Across HBV, HCV, HDV, and Fibrosis, Including Late-Breaking Data on Hepcludex® in HDV, Demonstrate Gilead’s Commitment to Addressing Unmet Needs for...

COVID-19 Antiviral Veklury Approved for Use in Patients With Severe Renal Impairment - Vimarsana News

COVID-19 Antiviral Veklury Approved for Use in Patients With Severe Renal Impairment

The FDA has approved Veklury to include treatment of COVID-19 in patients with severe impairment, including those on dialysis.

FDA grants approval for Veklury use in Covid-19 patients - Vimarsana News

FDA grants approval for Veklury use in Covid-19 patients

The FDA has granted clearance to Gilead Sciences’ supplemental new drug application (sNDA) of Veklury (remdesivir) for use in Covid-19 patients.